Skip to main content

Correction to: Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride

The Original Article was published on 13 May 2022

Correction to: Allergy, Asthma & Clinical Immunology (2022) 18:41 https://doi.org/10.1186/s13223-022-00677-z

In this article [1], the affiliation 'Department of Biomedical Sciences—Humanitas University—Pieve Emanuele (MI), Italy' for Giorgio W. Canonica was missing. It has been corrected with this correction.

Reference

  1. Ansotegui IJ, Bernstein JA, Canonica GW, Gonzalez-Diaz SN, Martin BL, Morais-Almeida M, Murrieta-Aguttes M, Sanchez Borges M. Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride. Allergy Asthma Clin Immunol. 2022;18:41. https://doi.org/10.1186/s13223-022-00677-z.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ignacio J. Ansotegui.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ansotegui, I.J., Bernstein, J.A., Canonica, G.W. et al. Correction to: Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride. Allergy Asthma Clin Immunol 18, 65 (2022). https://doi.org/10.1186/s13223-022-00705-y

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13223-022-00705-y